Here are some of the stocks that may see significant price movement today.
EBITDA for the quarter dipped 99% y-o-y to ₹17 Crore. In the comparable period, EBITDA for Q2 FY26 was at ₹1,707 Crore.
Revenue also inched up, coming in at ₹7,249.6 crore against ₹6,760.4 crore last year.
Alembic’s version has been cleared as therapeutically equivalent to Cardizem Tablets, the reference drug marketed by Bausch Health US LLC.
The Company is addressing a fast-growing residential and commercial solar market.
In October 2025, debt funds led the outflows, but equity price accretion largely made up for it
Gross SIP flows in Oct-25 got tantalizingly close to ₹30,000 Crore, as SIP stoppage also moderated
The missile is launched via the bank’s gun barrel and is known for its high hit probability at higher ranges.
In terms of yoy percentage change in AUM; sectors like Aviation, Retail, and Metals/Mining are the unlikely stars
As part of the agreement, the Trust will pay ₹9,270 crore to NHAI as the upfront concession fee.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
